TP53 and central nervous system cancer: In vitro studies demonstrating that temozolomide-induced DNA damage response activates the ATM kinase and subsequent phosphorylation of p53 on Ser15 have been reported in several types of cancer, including human B lymphoblastoid cell line [27], melanoma cells [28] and glioma cells [29].